The trials showed an effect on Alzheimer's biomarkers, though Novo did not specify which ones.
GLP-1s fail to slow progression of Alzheimer’s: Novo Nordisk
The Hill Healthcare11/25124
The Hill Healthcare11/25
Local News in Massachusetts
Cover Media
The radio station 99.5 The Apple
NBC News
CNN
ScienceAlert en Español
Healthcare Dive
The ConversationLooks like you've reached the bottom
United State
English
The Hill Healthcare11/25